4//SEC Filing
Carr Patricia 4
Accession 0001784606-25-000004
CIK 0001232524other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 6:13 PM ET
Size
10.1 KB
Accession
0001784606-25-000004
Insider Transaction Report
Form 4
Carr Patricia
SVP, Chief Accounting Officer
Transactions
- Sale
Ordinary Shares
2025-11-18$181.66/sh−69$12,535→ 7,012 total - Exercise/Conversion
Ordinary Shares
2025-11-18$136.18/sh+5,250$714,945→ 12,262 total - Sale
Ordinary Shares
2025-11-18$182.07/sh−5,250$955,868→ 7,012 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-11-18−5,250→ 0 totalExercise: $136.18Exp: 2027-03-01→ Ordinary Shares (5,250 underlying)
Footnotes (2)
- [F1]The Reporting Person acquired 69 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.
- [F2]These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2021.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001784606
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 6:13 PM ET
- Size
- 10.1 KB